NIDA launches drug education booklet series for middle school students

Mind Matters: A series for Young People

The National Institute on Drug Abuse (NIDA) has launched a redesigned series of booklets geared towards educating middle school students about substance use.

The Mind Matters series consists of nine booklets on various drug topics. The series was designed to help students in grades 5 through 8 understand the effects and consequences of drug use on the brain and body. The accompanying online Teacher’s Guide includes science-based information and engaging activities to enhance learning. In addition, short video clips are available to supplement the lessons.

Each of the booklets in the Mind Matters series is devoted to a specific drug or drug topic, including Drugs and the Brain, Cocaine, Inhalants, K2 Spice and Bath Salts, Marijuana, Methamphetamine, Nicotine, Opioids, and Prescription Stimulants.

Both English and Spanish booklets, as well as the accompanying Teacher’s Guide, are all available online in printable PDFs.

Go to the Mind Matters (formerly known as Mind Over Matter) publications

For more information, contact the NIDA press office at or 301-443-6245. Follow NIDA on Twitter and Facebook.

NIDA Press Office

About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH…Turning Discovery Into Health®